Scientist working on ChulaCov19 COVID-19 vaccine

Thailand launches third phase of GPO’s inactivated COVID vaccine trials

Thailand’s Government Pharmaceutical Organisation (GPO) launched the third phase of human trials of its COVID HXP-GPOVac on 4,000 volunteers today (Friday), after the success of the second phase involving 300 volunteers.

Each volunteer will be given two doses of vaccine, of 10 micrograms each at least 14 days apart, after which their blood will be taken for tests, to check the level of immunity. Doctors will also assess the safety of the vaccine in humans and compare its efficacy against that of the AstraZeneca vaccine, which is also an inactivated vaccine. The vaccine will be used as booster.

Full story:

By Thai PBS World


The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours